ロード中...
Feasibility study of using high-throughput drug sensitivity testing to target recurrent glioblastoma stem cells for individualized treatment
Abstract Background Despite the well described heterogeneity in glioblastoma (GBM), treatment is standardized, and clinical trials investigate treatment effects at population level. Genomics-driven oncology for stratified treatments allow clinical decision making in only a small minority of screened...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wiley
2019-12-01
|
| シリーズ: | Clinical and Translational Medicine |
| 主題: | |
| オンライン･アクセス: | http://link.springer.com/article/10.1186/s40169-019-0253-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|